Happy 75% Chaos 20% Sad 5% Well 80% Anger 10% Fear 5% Surprise 30% » Clinical Trials » Permalink » Source ▲ 0 ▼ ASCO26: BMS and J&J debut shining multiple myeloma data Both BMS and J&J touted positive data for their multiple myeloma drugs at ASCO 2026. More in Clinical Trials →
No comments yet.